Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Influenza

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 138 articles:
HTML format



Single Articles


    August 2020
  1. ROTHAN HA, Stone S, Natekar J, Kumari P, et al
    The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.
    Virology. 2020;547:7-11.
    PubMed     Abstract available


    July 2020
  2. SHI F, Wu T, Zhu X, Ge Y, et al
    Association of viral load with serum biomakers among COVID-19 cases.
    Virology. 2020;546:122-126.
    PubMed     Abstract available


    June 2020
  3. WOODS PS, Doolittle LM, Rosas LE, Nana-Sinkam SP, et al
    Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.
    Virology. 2020;545:40-52.
    PubMed     Abstract available


    March 2020
  4. LIU R, Sreenivasan C, Yu H, Sheng Z, et al
    Influenza D virus diverges from its related influenza C virus in the recognition of 9-O-acetylated N-acetyl- or N-glycolyl-neuraminic acid-containing glycan receptors.
    Virology. 2020;545:16-23.
    PubMed     Abstract available


    February 2020
  5. FANG QQ, Huang WJ, Li XY, Cheng YH, et al
    Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
    Virology. 2020;545:1-9.
    PubMed     Abstract available


  6. PURANIK A, Slomka MJ, Warren CJ, Thomas SS, et al
    Transmission dynamics between infected waterfowl and terrestrial poultry: Differences between the transmission and tropism of H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4a) among ducks, chickens and turkeys.
    Virology. 2020;541:113-123.
    PubMed     Abstract available


    January 2020
  7. ZOU S, Tang J, Zhang Y, Liu L, et al
    Molecular characterization of H3 subtype avian influenza viruses based on poultry-related environmental surveillance in China between 2014 and 2017.
    Virology. 2020;542:8-19.
    PubMed     Abstract available


  8. STRAUS MR, Kinder JT, Segall M, Dutch RE, et al
    SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
    Virology. 2020;543:43-53.
    PubMed     Abstract available


    November 2019
  9. LONDRIGAN SL, Wakim LM, Smith J, Haverkate AJ, et al
    IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.
    Virology. 2019;540:17-22.
    PubMed     Abstract available


  10. RODRIGUEZ P, Marcos-Villar L, Zamarreno N, Yanguez E, et al
    Mutations of the segment-specific nucleotides at the 3' end of influenza virus NS segment control viral replication.
    Virology. 2019;539:104-113.
    PubMed     Abstract available


    September 2019
  11. YANG J, Xie D, Nie Z, Xu B, et al
    Inferring host roles in bayesian phylodynamics of global avian influenza A virus H9N2.
    Virology. 2019;538:86-96.
    PubMed     Abstract available


  12. SHENG T, Sun Y, Sun J, Prinz RA, et al
    Role of TGF-beta-activated kinase 1 (TAK1) activation in H5N1 influenza A virus-induced c-Jun terminal kinase activation and virus replication.
    Virology. 2019;537:263-271.
    PubMed     Abstract available


    August 2019
  13. ZHANG S, Huo C, Xiao J, Fan T, et al
    p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.
    Virology. 2019;537:110-120.
    PubMed     Abstract available


  14. LEYSON C, Youk SS, Smith D, Dimitrov K, et al
    Pathogenicity and genomic changes of a 2016 European H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4) in experimentally infected mallards and chickens.
    Virology. 2019;537:172-185.
    PubMed     Abstract available


  15. PATEL H, Kukol A
    Prediction of ligands to universally conserved binding sites of the influenza a virus nuclear export protein.
    Virology. 2019;537:97-103.
    PubMed     Abstract available


  16. PULIT-PENALOZA JA, Belser JA, Tumpey TM, Maines TR, et al
    Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015).
    Virology. 2019;537:31-35.
    PubMed     Abstract available


  17. TROST JF, Wang W, Liang B, Galloway SE, et al
    A conserved histidine in Group-1 influenza subtype hemagglutinin proteins is essential for membrane fusion activity.
    Virology. 2019;536:78-90.
    PubMed     Abstract available


  18. GE Y, Chi Y, Min X, Zhao K, et al
    The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Virology. 2019;536:58-67.
    PubMed     Abstract available


  19. DE VLUGT C, Sikora D, Rocheleau L, Pelchat M, et al
    Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA.
    Virology. 2019;536:91-100.
    PubMed     Abstract available


    July 2019
  20. SUN X, Belser JA, Yang H, Pulit-Penaloza JA, et al
    Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.
    Virology. 2019;535:232-240.
    PubMed     Abstract available


  21. HAO X, Wang X, Hu J, Gu M, et al
    The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens.
    Virology. 2019;535:218-226.
    PubMed     Abstract available


  22. KIM KH, Lee YT, Park S, Jung YJ, et al
    Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Virology. 2019;535:179-188.
    PubMed     Abstract available


    June 2019
  23. XIAO Y, Park JK, Williams S, Ramuta M, et al
    Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.
    Virology. 2019;534:96-107.
    PubMed     Abstract available


  24. NICHOLS JE, Niles JA, Fleming EH, Roberts NJ, et al
    The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.
    Virology. 2019;534:80-86.
    PubMed     Abstract available


  25. BERGMANN S, Elbahesh H
    Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses.
    Virology. 2019;534:54-63.
    PubMed     Abstract available


    May 2019
  26. YANG G, Chowdury S, Hodges E, Rahman MZ, et al
    Detection of highly pathogenic avian influenza A(H5N6) viruses in waterfowl in Bangladesh.
    Virology. 2019;534:36-44.
    PubMed     Abstract available


  27. LEE Y, Ko EJ, Kim KH, Lee YT, et al
    A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Virology. 2019;534:1-13.
    PubMed     Abstract available


  28. OHTA K, Matsumoto Y, Nishio M
    Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.
    Virology. 2019;533:108-114.
    PubMed     Abstract available


  29. MINE J, Uchida Y, Nakayama M, Tanikawa T, et al
    Genetics and pathogenicity of H5N6 highly pathogenic avian influenza viruses isolated from wild birds and a chicken in Japan during winter 2017-2018.
    Virology. 2019;533:1-11.
    PubMed     Abstract available


    April 2019
  30. TRIGUEIRO-LOURO JM, Correia V, Santos LA, Guedes RC, et al
    To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.
    Virology. 2019 Apr 27. pii: S0042-6822(19)30109.
    PubMed     Abstract available


  31. MA J, Shen H, McDowell C, Liu Q, et al
    Virus survival and fitness when multiple genotypes and subtypes of influenza A viruses exist and circulate in swine.
    Virology. 2019;532:30-38.
    PubMed     Abstract available


    March 2019
  32. TAKIZAWA N, Ogura Y, Fujita Y, Noda T, et al
    Local structural changes of the influenza A virus ribonucleoprotein complex by single mutations in the specific residues involved in efficient genome packaging.
    Virology. 2019;531:126-140.
    PubMed     Abstract available


  33. YUMINE N, Matsumoto Y, Ohta K, Fukasawa M, et al
    Claudin-1 inhibits human parainfluenza virus type 2 dissemination.
    Virology. 2019;531:93-99.
    PubMed     Abstract available


    February 2019
  34. REN L, Zhang W, Han P, Zhang J, et al
    Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible factor-1alpha via inhibition of proteasome.
    Virology. 2019;530:51-58.
    PubMed     Abstract available


  35. ZHANG T, Zhao H, Wang J, Han GZ, et al
    Wild birds do not harbor higher diversity of influenza virus internal genes than poultry.
    Virology. 2019;530:59-64.
    PubMed     Abstract available


    January 2019
  36. SANADA T, Yasui F, Honda T, Kayesh MEH, et al
    Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri).
    Virology. 2019;529:101-110.
    PubMed     Abstract available


  37. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    PubMed     Abstract available


  38. KWON JH, Noh JY, Jeong JH, Jeong S, et al
    Different pathogenicity of two strains of clade 2.3.4.4c H5N6 highly pathogenic avian influenza viruses bearing different PA and NS gene in domestic ducks.
    Virology. 2019;530:11-18.
    PubMed     Abstract available


  39. JESTER B, Uyeki TM, Jernigan DB, Tumpey TM, et al
    Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.
    Virology. 2019;527:32-37.
    PubMed     Abstract available


  40. SREENIVASAN CC, Thomas M, Antony L, Wormstadt T, et al
    Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types.
    Virology. 2019;528:152-163.
    PubMed     Abstract available


  41. LIU L, Wang T, Wang M, Tong Q, et al
    Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
    Virology. 2019;529:7-15.
    PubMed     Abstract available


  42. ZOU S, Zhang Y, Li X, Bo H, et al
    Molecular characterization and receptor binding specificity of H9N2 avian influenza viruses based on poultry-related environmental surveillance in China between 2013 and 2016.
    Virology. 2019;529:135-143.
    PubMed     Abstract available


  43. NIKOLAIDIS M, Mimouli K, Kyriakopoulou Z, Tsimpidis M, et al
    Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses.
    Virology. 2019;526:72-80.
    PubMed     Abstract available


    December 2018
  44. MA LL, Zhang P, Wang HQ, Li YF, et al
    heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-alpha/beta.
    Virology. 2018;528:80-88.
    PubMed     Abstract available


  45. OHTSUKA J, Matsumoto Y, Ohta K, Fukumura M, et al
    Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.
    Virology. 2018;528:54-63.
    PubMed     Abstract available


    November 2018
  46. HIONO T, Matsuda A, Wagatsuma T, Okamatsu M, et al
    Lectin microarray analyses reveal host cell-specific glycan profiles of the hemagglutinins of influenza A viruses.
    Virology. 2018;527:132-140.
    PubMed     Abstract available


  47. BELSER JA, Maines TR, Tumpey TM
    Importance of 1918 virus reconstruction to current assessments of pandemic risk.
    Virology. 2018;524:45-55.
    PubMed     Abstract available


    October 2018
  48. NICOL MQ, Campbell GM, Shaw DJ, Dransfield I, et al
    Lack of IFNgamma signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.
    Virology. 2018;526:155-164.
    PubMed     Abstract available


  49. WANG SC, Liao HY, Zhang JY, Cheng TR, et al
    Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Virology. 2018;526:125-137.
    PubMed     Abstract available


  50. ZHANG J, Ruan T, Sheng T, Wang J, et al
    Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.
    Virology. 2018;526:1-12.
    PubMed     Abstract available


  51. MARCHENKO V, Goncharova N, Susloparov I, Kolosova N, et al
    Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia.
    Virology. 2018;525:216-223.
    PubMed     Abstract available


  52. NARKPUK J, Jongkaewwattana A, Teeravechyan S
    The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin.
    Virology. 2018;525:161-169.
    PubMed     Abstract available


  53. GONZALEZ-PARRA G, Dobrovolny HM
    A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.
    Virology. 2018;523:129-139.
    PubMed     Abstract available


  54. MORGENE MF, Maurin C, Pillet S, Berthelot P, et al
    HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.
    Virology. 2018;523:27-34.
    PubMed     Abstract available


    September 2018
  55. YAN LM, Li OTW, Poh CM, Perera RAPM, et al
    Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.
    Virology. 2018;525:73-82.
    PubMed     Abstract available


  56. CUI L, Mahesutihan M, Zheng W, Meng L, et al
    CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein.
    Virology. 2018;525:40-47.
    PubMed     Abstract available


  57. LI L, DeLiberto TJ, Killian ML, Torchetti MK, et al
    Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Virology. 2018;525:32-39.
    PubMed     Abstract available


  58. XIAO Y, Nolting JM, Sheng ZM, Bristol T, et al
    Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.
    Virology. 2018;524:182-191.
    PubMed     Abstract available


  59. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Abstract available


    August 2018
  60. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
    The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Virology. 2018;524:90-96.
    PubMed     Abstract available


  61. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    PubMed     Abstract available


  62. SHIBATA A, Okamatsu M, Sumiyoshi R, Matsuno K, et al
    Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers.
    Virology. 2018;524:10-17.
    PubMed     Abstract available


    July 2018
  63. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
    Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
    Virology. 2018;523:22-26.
    PubMed     Abstract available


  64. WANG Z, Huang B, Thomas M, Sreenivasan CC, et al
    Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus.
    Virology. 2018;522:131-137.
    PubMed     Abstract available


  65. CORREIA V, Abecasis AB, Rebelo-de-Andrade H
    Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.
    Virology. 2018;522:122-130.
    PubMed     Abstract available


  66. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
    Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Virology. 2018;522:65-72.
    PubMed     Abstract available


  67. GAMBARYAN AS, Matrosovich TY, Boravleva EY, Lomakina NF, et al
    Receptor-binding properties of influenza viruses isolated from gulls.
    Virology. 2018;522:37-45.
    PubMed     Abstract available


    May 2018
  68. LI Y, Sun L, Zheng W, Madina Mahesutihan, et al
    Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus.
    Virology. 2018;520:30-38.
    PubMed     Abstract available


    April 2018
  69. LI J, Zhang K, Chen Q, Zhang X, et al
    Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
    Virology. 2018;519:64-73.
    PubMed     Abstract available


    March 2018
  70. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
    Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
    Virology. 2018;518:313-323.
    PubMed     Abstract available


  71. CHRZASTEK K, Lee DH, Gharaibeh S, Zsak A, et al
    Characterization of H9N2 avian influenza viruses from the Middle East demonstrates heterogeneity at amino acid position 226 in the hemagglutinin and potential for transmission to mammals.
    Virology. 2018;518:195-201.
    PubMed     Abstract available


    February 2018
  72. ZHANG S, Cheng Q, Luo C, Yin L, et al
    An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N(0)-P interaction and maintaining N solubility.
    Virology. 2018;518:64-76.
    PubMed     Abstract available


  73. RAMEY AM, DeLiberto TJ, Berhane Y, Swayne DE, et al
    Lessons learned from research and surveillance directed at highly pathogenic influenza A viruses in wild birds inhabiting North America.
    Virology. 2018;518:55-63.
    PubMed     Abstract available


  74. RAJAO DS, Anderson TK, Kitikoon P, Stratton J, et al
    Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.
    Virology. 2018;518:45-54.
    PubMed     Abstract available


    January 2018
  75. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
    Development of a novel equine influenza virus live-attenuated vaccine.
    Virology. 2018;516:76-85.
    PubMed     Abstract available


  76. OISHI K, Yamayoshi S, Kawaoka Y
    Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast.
    Virology. 2018;516:71-75.
    PubMed     Abstract available


  77. LEE YN, Lee EK, Song BM, Heo GB, et al
    Evaluation of the zoonotic potential of multiple subgroups of clade 2.3.4.4 influenza A (H5N8) virus.
    Virology. 2018;516:38-45.
    PubMed     Abstract available


    December 2017
  78. SUN H, Yao W, Wang K, Qian Y, et al
    Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.
    Virology. 2017;514:230-239.
    PubMed     Abstract available


  79. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    PubMed     Abstract available


    November 2017
  80. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
    Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Virology. 2017;511:123-134.
    PubMed     Abstract available


    October 2017
  81. NI F, Kondrashkina E, Wang Q
    Determinant of receptor-preference switch in influenza hemagglutinin.
    Virology. 2017;513:98-107.
    PubMed     Abstract available


  82. LION A, Richard M, Esnault E, Kut E, et al
    Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
    Virology. 2017;513:29-42.
    PubMed     Abstract available


  83. LAU JW, Kim YI, Murphy R, Newman R, et al
    Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
    Virology. 2017;510:289-296.
    PubMed     Abstract available


  84. YE Z, Ren L, Tang Z, Deng Y, et al
    Pulmonary C-fiber degeneration downregulates IFN-gamma receptor 1 via IFN-alpha induction to attenuate RSV-induced airway hyperresponsiveness.
    Virology. 2017;510:262-272.
    PubMed     Abstract available


    September 2017
  85. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
    Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
    Virology. 2017;512:8-20.
    PubMed     Abstract available


  86. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
    An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Virology. 2017;511:214-221.
    PubMed     Abstract available


    August 2017
  87. CHEN W, Xu Q, Zhong Y, Yu H, et al
    Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses.
    Virology. 2017;511:193-206.
    PubMed     Abstract available


  88. NAGUIB MM, Arafa AS, Parvin R, Beer M, et al
    Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt.
    Virology. 2017;511:165-174.
    PubMed     Abstract available


  89. BELSER JA, Johnson A, Pulit-Penaloza JA, Pappas C, et al
    Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
    Virology. 2017;511:135-141.
    PubMed     Abstract available


  90. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
    Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Virology. 2017;511:142-151.
    PubMed     Abstract available


  91. ABENTE EJ, Gauger PC, Walia RR, Rajao DS, et al
    Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.
    Virology. 2017;511:56-65.
    PubMed     Abstract available


  92. ROJO GL, Goya S, Orellana M, Sancilio A, et al
    Unravelling respiratory syncytial virus outbreaks in Buenos Aires, Argentina: Molecular basis of the spatio-temporal transmission.
    Virology. 2017;508:118-126.
    PubMed     Abstract available


    July 2017
  93. NGUYEN LT, Nishi T, Shichinohe S, Chu DH, et al
    Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
    Virology. 2017;510:252-261.
    PubMed     Abstract available


  94. BAJIMAYA S, Frankl T, Hayashi T, Takimoto T, et al
    Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
    Virology. 2017;510:234-241.
    PubMed     Abstract available


  95. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
    Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
    Virology. 2017;507:123-134.
    PubMed     Abstract available


    June 2017
  96. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al
    Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
    Virology. 2017;509:167-177.
    PubMed     Abstract available


  97. CHLANDA P
    Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
    Virology. 2017;509:131-132.
    PubMed     Abstract available


  98. PATEL H, Kukol A
    Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
    Virology. 2017;509:112-120.
    PubMed     Abstract available


  99. SMITH GE, Sun X, Bai Y, Liu YV, et al
    Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Virology. 2017;509:90-97.
    PubMed     Abstract available


  100. DENG L, Kim JR, Chang TZ, Zhang H, et al
    Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Virology. 2017;509:82-89.
    PubMed     Abstract available


    May 2017
  101. WANG BX, Brown EG, Fish EN
    Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
    Virology. 2017;508:170-179.
    PubMed     Abstract available


  102. SUN X, Belser JA, Pulit-Penaloza JA, Creager HM, et al
    Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Virology. 2017;508:164-169.
    PubMed     Abstract available


  103. LIN CY, Chia MY, Chen PL, Yeh CT, et al
    Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
    Virology. 2017;508:159-163.
    PubMed     Abstract available


  104. XU G, Zhang X, Liu Q, Bing G, et al
    PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine.
    Virology. 2017;508:45-53.
    PubMed     Abstract available


    April 2017
  105. LEE DH, Torchetti MK, Killian ML, Swayne DE, et al
    Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016.
    Virology. 2017;507:216-219.
    PubMed     Abstract available


  106. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al
    Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
    Virology. 2017;507:32-39.
    PubMed     Abstract available


  107. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
    Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
    Virology. 2017;504:63-72.
    PubMed     Abstract available


    March 2017
  108. NARKPUK J, Teeravechyan S, Puthavathana P, Jongkaewwattana A, et al
    Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism.
    Virology. 2017;506:99-109.
    PubMed     Abstract available


  109. FOUGEROLLE S, Legrand L, Lecouturier F, Sailleau C, et al
    Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.
    Virology. 2017;505:210-217.
    PubMed     Abstract available


    February 2017
  110. CHEN LJ, Lin XD, Tian JH, Liao Y, et al
    Diversity, evolution and population dynamics of avian influenza viruses circulating in the live poultry markets in China.
    Virology. 2017;505:33-41.
    PubMed     Abstract available


  111. CHAIMAYO C, Hayashi T, Underwood A, Hodges E, et al
    Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.
    Virology. 2017;505:23-32.
    PubMed     Abstract available


  112. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    PubMed     Abstract available


    January 2017
  113. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    PubMed     Abstract available


  114. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    PubMed     Abstract available


  115. RABBANI MA, Barik S
    5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus.
    Virology. 2017;503:46-51.
    PubMed     Abstract available


  116. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    PubMed     Abstract available


    December 2016
  117. PEARCE MB, Pappas C, Gustin KM, Davis CT, et al
    Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.
    Virology. 2016;502:114-122.
    PubMed     Abstract available


  118. SUPTAWIWAT O, Ninpan K, Boonarkart C, Ruangrung K, et al
    Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Virology. 2016;502:84-96.
    PubMed     Abstract available


  119. BELSER JA, Sun X, Creager HM, Johnson A, et al
    Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.
    Virology. 2016;502:13-19.
    PubMed     Abstract available


  120. PUSHKO P, Tretyakova I, Hidajat R, Zsak A, et al
    Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
    Virology. 2016;501:176-182.
    PubMed     Abstract available


  121. BAJIMAYA S, Hayashi T, Frankl T, Bryk P, et al
    Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
    Virology. 2016;501:127-135.
    PubMed     Abstract available


    November 2016
  122. HU M, Yuan S, Zhang K, Singh K, et al
    PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.
    Virology. 2016;501:92-101.
    PubMed     Abstract available


  123. LUO J, Ferguson L, Smith DR, Woolums AR, et al
    Serological evidence for high prevalence of Influenza D Viruses in Cattle, Nebraska, United States, 2003-2004.
    Virology. 2016;501:88-91.
    PubMed     Abstract available


  124. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology. 2016;500:209-217.
    PubMed     Abstract available


  125. KOSIK I, Yewdell JW
    Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.
    Virology. 2016;500:178-183.
    PubMed     Abstract available


  126. GONZALEZ Y, Juarez E, Carranza C, Sada E, et al
    Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus.
    Virology. 2016;500:139-148.
    PubMed     Abstract available


  127. HARTWIG SM, Ketterer M, Apicella MA, Varga SM, et al
    Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.
    Virology. 2016;498:128-35.
    PubMed     Abstract available


    October 2016
  128. GUJJAR N, Chothe SK, Gawai S, Nissly R, et al
    Co-expression of sialic acid receptors compatible with avian and human influenza virus binding in emus (Dromaius novaehollandiae).
    Virology. 2016;500:114-121.
    PubMed     Abstract available


  129. CREAGER HM, Zeng H, Pulit-Penaloza JA, Maines TR, et al
    In vitro exposure system for study of aerosolized influenza virus.
    Virology. 2016;500:62-70.
    PubMed     Abstract available


  130. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
    Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Virology. 2016;500:1-10.
    PubMed     Abstract available


  131. ELBAHESH H, Bergmann S, Russell CJ
    Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.
    Virology. 2016;499:369-374.
    PubMed     Abstract available


  132. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
    A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Virology. 2016;499:288-297.
    PubMed     Abstract available


  133. SHRIVASTAVA P, Sarkar I, Atanley E, Gomis S, et al
    IL-12p40 gene-deficient BALB/c mice exhibit lower weight loss, reduced lung pathology and decreased sensitization to allergen in response to infection with pneumonia virus of mice.
    Virology. 2016;497:1-10.
    PubMed     Abstract available


    September 2016
  134. CUI P, Deng G, Shi J, Kong H, et al
    New influenza A(H7N7) viruses detected in live poultry markets in China.
    Virology. 2016;499:165-169.
    PubMed     Abstract available


  135. DEJESUS E, Costa-Hurtado M, Smith D, Lee DH, et al
    Changes in adaptation of H5N2 highly pathogenic avian influenza H5 clade 2.3.4.4 viruses in chickens and mallards.
    Virology. 2016;499:52-64.
    PubMed     Abstract available


  136. ISHIKAWA H, Fukui T, Ino S, Sasaki H, et al
    Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
    Virology. 2016;499:23-29.
    PubMed     Abstract available


  137. RAUFF D, Strydom C, Abolnik C
    Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
    Virology. 2016;498:226-239.
    PubMed     Abstract available


    April 2016
  138. HWANG HS, Lee YT, Kim KH, Park S, et al
    Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Virology. 2016;494:215-224.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: